Estimated antiretroviral therapy coverage among people living with HIV in Serbia
Serbia: Estimated antiretroviral therapy coverage among people living with HIV was 71.0% in 2025. ▲ Rising
Estimated antiretroviral therapy coverage among people living with HIV in Serbia, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
Serbia recorded 71.0% for estimated antiretroviral therapy coverage among people living with hiv in 2025. That is the highest value across all 26 years on record.
The figure is up 2.9% on the previous year and up 51.1% over ten years.
Over the whole period, estimated antiretroviral therapy coverage among people living with hiv in Serbia peaked at 71.0% in 2025 and was at its lowest, 0.0%, in 2000.
Serbia ranks 80th of 143 countries on this measure, in the middle of the range.
The long-run direction has been consistently rising across the 26 years of available data.
Estimated antiretroviral therapy coverage among people living with HIV in Serbia, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 24.0% | — |
| 2004 | 30.0% | +25.0% |
| 2005 | 35.0% | +16.7% |
| 2006 | 35.0% | +0.0% |
| 2007 | 35.0% | +0.0% |
| 2008 | 36.0% | +2.9% |
| 2009 | 36.0% | +0.0% |
| 2010 | 38.0% | +5.6% |
| 2011 | 40.0% | +5.3% |
| 2012 | 41.0% | +2.5% |
| 2013 | 42.0% | +2.4% |
| 2014 | 44.0% | +4.8% |
| 2015 | 47.0% | +6.8% |
| 2016 | 51.0% | +8.5% |
| 2017 | 55.0% | +7.8% |
| 2018 | 60.0% | +9.1% |
| 2019 | 62.0% | +3.3% |
| 2020 | 62.0% | +0.0% |
| 2021 | 64.0% | +3.2% |
| 2022 | 66.0% | +3.1% |
| 2023 | 68.0% | +3.0% |
| 2024 | 69.0% | +1.5% |
| 2025 | 71.0% | +2.9% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 23.1% | 0.0% | 36.0% | 10 |
| 2010s | 48.0% | 38.0% | 62.0% | 10 |
| 2020s | 66.7% | 62.0% | 71.0% | 6 |
Countries ranked near Serbia
- 80 Cuba 71.0% compare
- 80 Brazil 71.0% compare
- 80 El Salvador 71.0% compare
- 80 Congo, Democratic Republic of the 71.0% compare
- 80 Gabon 71.0% compare
More health data for Serbia
- Un projection of annual infant deaths, annual growth rate -5.26 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.3584 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,502 deaths per 1,000 people (2090)
- Number of infants who die before age 1 18 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -2.67 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.022 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.67 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is estimated antiretroviral therapy coverage among people living with hiv in Serbia?
- Estimated antiretroviral therapy coverage among people living with hiv in Serbia was 71.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest estimated antiretroviral therapy coverage among people living with hiv recorded in Serbia?
- The highest recorded value was 71.0% in 2025.
- What is the lowest estimated antiretroviral therapy coverage among people living with hiv recorded in Serbia?
- The lowest recorded value was 0.0% in 2000.
- How does Serbia rank for estimated antiretroviral therapy coverage among people living with hiv?
- Serbia ranks 80th out of 143 countries with data for 2025.
- Is estimated antiretroviral therapy coverage among people living with hiv rising or falling in Serbia?
- Over the last ten years it is up 51.1%. The long-run trend across the full record is rising.
- Where does this Serbia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).